Skip to main content
Premium Trial:

Request an Annual Quote

Nucleai: Oscar Puig, Suzana Couto

Nucleai, a Tel Aviv, Israel-based company specializing in AI-powered spatial biology, has appointed Oscar Puig as VP of translational medicine and diagnostics, and Suzana Couto as a scientific advisor.

Puig has worked at Bristol-Myers Squibb, Roche/Genetech, Merck, BeiGene, Lilly, and Phosphorus Diagnostics. He specializes in clinical biomarkers and companion diagnostics, and has more than 50 peer-reviewed publications to his name. He hold a PhD in molecular biology from the University of Valencia, Spain, and carried out his postdoctoral research at the European Molecular Biology Laboratory in Heidelberg, Germany.

Couto is head of pathology at Neomorph, and has more than 15 years of experience working in multiple stages of drug discovery. Prior to Neomorph, she led a digital pathology team at Genentech, and pathology teams at Celgene and Genmab. Before joining industry, Couto led a comparative pathology core serving Memorial Sloan Kettering Cancer Center, Rockefeller University, and Weill Cornell Medical School. She is a board certified veterinary pathologist and holds a PhD in comparative pathology from the University of California, Davis.